Meta analysis of correlation between coronary artery calcification score and coronary artery disease and all-cause mortality

doi:10.3969/j.issn.1004-583X.2021.04.001

Abstract

Abstract:

Objective To systematically review the correlations among coronary artery calcification score(CACS), coronary artery disease and all-cause mortality. Methods The databases of Pubmed, The Cochrane Library, EMbase, CKNI and WanFang Data were electronically searched to collect cohort studies on the correlations between CACS, CAD and all-cause mortality from the inception of databases to June 2020. Meta analysis was performed with Stata 14.0 software when two data clerks independently screened literatures, they extracted data and assessed risk of bias of included studies. Results A total of 11 cohort studies were included, including 59 143 cases. The Meta results showed that CACS≤100 group [HR=2.46,95%CI(1.77,3.41),P=0.000,I²=55.5%],100<CACS≤400 group[HR=3.62,95%CI(2.24,5.83),P=0.000,I²=42.2%] and CACS>400 group [HR=5.09,95%CI(2.02,12.84),P=0.001,I²=70.7%] are more likely to occur CAD and all-cause deaths compared to CACS<10 group. Conclusion There is a higher risk of coronary artery disease and all-cause mortality for patients with CAC.

Key words: coronary artery disease, coronary artery calcification score(CACS), all-cause mortality, meta analysis

CLC Number:

R541.4

Bi Yue, Li Yongjun, Wang Mengmeng. Meta analysis of correlation between coronary artery calcification score and coronary artery disease and all-cause mortality[J]. Clinical Focus, 2021, 36(4): 293-302.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2021.04.001

https://huicui.hebmu.edu.cn/EN/Y2021/V36/I4/293

Figures/Tables 13

References 36

[1]	刘小清. 冠心病流行病学研究进展及疾病负担[J]. 中华心血管病杂志, 2008(6):573-576.
[2]	Hoffmann U, Massaro JM, Fox CS, et al. Defining normal distributions of coronary artery calcium in women and men (from the Framingham Heart Study)[J]. Am J Cardiol, 2008,102(9):1136-1141. doi: 10.1016/j.amjcard.2008.06.038 URL
[3]	Osawa K, Nakanishi R, Budoff M. Coronary artery calcification[J]. Global Heart, 2020,11(3):287-293. doi: 10.1016/j.gheart.2016.08.001 URL
[4]	Goff DJ, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol, 2014,63(25 Pt B):2935-2959. doi: 10.1016/j.jacc.2013.11.005 URL
[5]	Cardarelli R, Hall A, Rankin W. Coronary artery calcium progression is associated with cardiovascular events among asymptomatic individuals: From the north texas primary care practice-based research network (NorTex-PBRN)[J]. J Am Board Fam Med, 2017,30(5):592-600. doi: 10.3122/jabfm.2017.05.170032 pmid: 28923811
[6]	Ferencik M, Pencina KM, Liu T, et al. Coronary artery calcium distribution is an independent predictor of incident major coronary heart disease events: Results from the framingham heart study[J]. Circ Cardiovasc Imaging, 2017,10(10):e006592.
[7]	Yang J, Dou G, Tesche C, et al. Progression of coronary atherosclerotic plaque burden and relationship with adverse cardiovascular event in asymptomatic diabetic patients[J]. BMC Cardiovasc Disord, 2019,19(1):39. doi: 10.1186/s12872-019-1016-4 URL
[8]	孙奥松, 孙钢. 多层螺旋CT冠状动脉钙化积分的研究进展[J]. 医学影像学杂志, 2012(8):1401-1404.
[9]	Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol, 2010,56(25):e50-e103. doi: 10.1016/j.jacc.2010.09.001 URL
[10]	Curry SJ, Krist AH, Owens DK, et al. Risk assessment for cardiovascular disease with nontraditional risk factors: US preventive services task force recommendation statement[J]. JAMA, 2018,320(3):272-280. doi: 10.1001/jama.2018.8359 URL
[11]	Chaikriangkrai K, Velankar P, Schutt R, et al. Additive prognostic value of coronary artery calcium score over coronary computed tomographic angiography stenosis assessment in symptomatic patients without known coronary artery disease[J]. Am J Cardiol, 2015,115(6):738-744. doi: 10.1016/j.amjcard.2014.12.032 URL
[12]	Carr JJ, Jacobs DJ, Terry JG, et al. Association of coronary artery calcium in adults aged 32 to 46 years with incident coronary heart disease and death[J]. JAMA Cardiol, 2017,2(4):391-399. doi: 10.1001/jamacardio.2016.5493 URL
[13]	Chen J, Budoff MJ, Reilly MP, et al. Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease[J]. JAMA Cardiol, 2017,2(6):635. doi: 10.1001/jamacardio.2017.0363 URL
[14]	Paixao ARM, Ayers CR, El Sabbagh A, et al. Coronary artery calcium improves risk classification in younger populations[J]. JACC Cardiovasc Imaging, 2015,8(11):1285-1293. doi: 10.1016/j.jcmg.2015.06.015 pmid: 26476504
[15]	Greenland P, Labree L, Azen SP, et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals[J]. JAMA, 2004,291(2):210-215. pmid: 14722147
[16]	Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups[J]. N Engl J Med, 2008,358(13):1336-1345. doi: 10.1056/NEJMoa072100 URL
[17]	Elkeles RS, Godsland IF, Feher MD, et al. Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: The PREDICT study[J]. Eur Heart J, 2008,29(18):2244-2251. doi: 10.1093/eurheartj/ehn279 URL
[18]	Budoff MJ, Shaw LJ, Liu ST, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients[J]. J Am Coll Cardiol, 2007,49(18):1860-1870. doi: 10.1016/j.jacc.2006.10.079 URL
[19]	Budoff MJ, Mayrhofer T, Ferencik M, et al. Prognostic value of coronary artery calcium in the promise study (prospective multicenter imaging study for evaluation of chest pain)[J]. Circulation, 2017,136(21):1993-2005. doi: 10.1161/CIRCULATIONAHA.117.030578 pmid: 86696664965976072
[20]	Budoff M, Backlund JC, Bluemke DA, et al. The association of coronary artery calcification with subsequent incidence of cardiovascular disease in type 1 diabetes[J]. JACC Cardiovasc Imaging, 2019,12(7):1341-1349. doi: 10.1016/j.jcmg.2019.01.014 URL
[21]	Nakanishi R, Li D, Blaha MJ, et al. The relationship between coronary artery calcium score and the long-term mortality among patients with minimal or absent coronary artery risk factors[J]. Int J Cardiol, 2015,185:275-281. doi: 10.1016/j.ijcard.2015.03.146 URL
[22]	Chaikriangkrai K, Palamaner Subash Shantha G, Jhun HY, et al. Prognostic value of coronary artery calcium score in acute chest pain patients without known coronary artery disease: Systematic review and meta-analysis[J]. Ann Emerg Med, 2016,68(6):659-670. doi: S0196-0644(16)30400-0 pmid: 27765299
[23]	Arad Y, Goodman KJ, Roth M, et al. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events[J]. J Am Coll Cardiol, 2005,46(1):158-165. doi: 10.1016/j.jacc.2005.02.088 URL
[24]	Greenland P, Blaha MJ, Budoff MJ, et al. Coronary calcium score and cardiovascular risk[J]. J Am Coll Cardiol, 2018,72(4):434-447. doi: 10.1016/j.jacc.2018.05.027 URL
[25]	Hartaigh BÓ, Valenti V, Cho I, et al. 15-Year prognostic utility of coronary artery calcium scoring for all-cause mortality in the elderly[J]. Atherosclerosis, 2016,246:361-366. doi: 10.1016/j.atherosclerosis.2016.01.039 pmid: 26841073
[26]	Vliegenthart R, Oudkerk M, Hofman A, et al. Coronary calcification improves cardiovascular risk prediction in the elderly[J]. Circulation, 2005,112(4):572-577. pmid: 16009800
[27]	Nakanishi R, Li D, Blaha MJ, et al. All-cause mortality by age and gender based on coronary artery calcium scores[J]. Eur Heart J Cardiovasc Imaging, 2016,17(11):1305-1314. pmid: 26705490
[28]	Andersson C, Vasan RS. Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease?: Clinical risk scores are sufficient to define primary prevention treatment strategies among asymptomatic patients[J]. Circ Cardiovasc Imaging, 2014,7(2):390-397. doi: 10.1161/CIRCIMAGING.113.000470 URL
[29]	陈雪, 赵全明, 聂毛晓, 等. 冠状动脉钙化的形成、检测及治疗新进展[J]. 中国循证心血管医学杂志, 2019,11(1):122-123.
[30]	Shekar C, Budoff M. Calcification of the heart: mechanisms and therapeutic avenues[J]. Expert Rev Cardiovasc Ther, 2018,16(7):527-536. doi: 10.1080/14779072.2018.1484282 URL
[31]	涂小良. 冠状动脉钙化积分在心血管风险评估中的应用[D]. 南昌大学, 2017.
[32]	Gottlieb I, Miller JM, Arbab-Zadeh A, et al. The absence of coronary calcification does not exclude obstructive coronary artery disease or the need for revascularization in patients referred for conventional coronary angiography[J]. J Am Coll Cardiol, 2010,55(7):627-634. doi: 10.1016/j.jacc.2009.07.072 URL
[33]	Anand DV, Lim E, Hopkins D, et al. Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy[J]. Eur Heart J, 2006,27(6):713-721. doi: 10.1093/eurheartj/ehi808 URL
[34]	Bavishi C, Argulian E, Chatterjee S, et al. CACS and the frequency of stress-induced myocardial ischemia during MPI: A meta-analysis[J]. JACC Cardiovasc Imaging, 2016,9(5):580-589. doi: 10.1016/j.jcmg.2015.11.023 pmid: 27085440
[35]	Tota-Maharaj R, Blaha MJ, Mcevoy JW, et al. Coronary artery calcium for the prediction of mortality in young adults <45 years old and elderly adults >75 years old[J]. Eur Heart J, 2012,33(23):2955-2962. doi: 10.1093/eurheartj/ehs230 URL
[36]	Lee JH, Han D, O HB, et al. Warranty period of zero coronary artery calcium score for predicting all-cause mortality according to cardiac risk burden in asymptomatic korean adults[J]. Circ J, 2016,80(11):2356-2361. doi: 10.1253/circj.CJ-16-0731 URL

纳入研究	年限	试验类型	国家	样本量 (人)	平均年龄 (岁)	原始研究纳入标准及CACS分组	研究结局	平均随访时间(年)
Elkeles	2008	前瞻性研究	英国	589	63.1	无症状人群的T2DM,11~100,101~400,401~1000,1001~10000	心血管事件	4.0
Carr	2017	前瞻性研究	美国	5115	40.3±3.6	无症状人群,1~ 1 9,20~100,和>100	冠心病、心血管疾病、全因死亡率	12.5
Chaikrian	2015	回顾性研究	美国	805	58.0±13.0	有胸痛症状人群,1~100, 101~400,>400	心脏不良事件	2.3±0.9
Chen	2017	前瞻性研究	美国	1541	21~74	慢性肾衰竭患者,1~100,>100	心血管疾病、心肌梗死、心力衰竭和全因死亡率	5.9
Paixao	2015	前瞻性研究	美国	2084	44.4±9.0	无症状患者,1~10, 10~100,>100	冠心病事件	9.2±1.3
Greenland	2004	前瞻性研究	美国	1029	65.7±7.8	无症状人群1~100, 101~300,>300	非致命性心肌梗死或冠心病死亡	7.0
Budoff	2007	前瞻性研究	美国	25253	56.0±11.0	无症状患者,1~10,11~100,101~399,400~699, 700~999,>1000	全因死亡率	6.8±3.0
Detrano	2008	前瞻性研究	美国	6722	62.2±10.2	无症状人群,1~100,101~300,>300	冠状动脉事件	3.8
Nakanishi	2015	回顾性研究	美国	5584	56.6±11.6	无症状人群,1~99,100~399, ≥400	全因死亡率	10.4±3.1
Budoff	2017	前瞻性研究	美国	4209	60.6±8.2	有胸痛症状人群,1~ 100, 101~400,和>400	心血管不良事件	2.2
Budoff	2019	前瞻性研究	美国	1205	42.8 ±6.8	无症状人群伴有1型糖尿病, 1~100,101~300,和>300	心血管不良事件	7~9

纳入研究	年限	试验类型	国家	样本量 (人)	平均年龄 (岁)	原始研究纳入标准及CACS分组	研究结局	平均随访时间(年)
Elkeles	2008	前瞻性研究	英国	589	63.1	无症状人群的T2DM,11~100,101~400,401~1000,1001~10000	心血管事件	4.0
Carr	2017	前瞻性研究	美国	5115	40.3±3.6	无症状人群,1~ 1 9,20~100,和>100	冠心病、心血管疾病、全因死亡率	12.5
Chaikrian	2015	回顾性研究	美国	805	58.0±13.0	有胸痛症状人群,1~100, 101~400,>400	心脏不良事件	2.3±0.9
Chen	2017	前瞻性研究	美国	1541	21~74	慢性肾衰竭患者,1~100,>100	心血管疾病、心肌梗死、心力衰竭和全因死亡率	5.9
Paixao	2015	前瞻性研究	美国	2084	44.4±9.0	无症状患者,1~10, 10~100,>100	冠心病事件	9.2±1.3
Greenland	2004	前瞻性研究	美国	1029	65.7±7.8	无症状人群1~100, 101~300,>300	非致命性心肌梗死或冠心病死亡	7.0
Budoff	2007	前瞻性研究	美国	25253	56.0±11.0	无症状患者,1~10,11~100,101~399,400~699, 700~999,>1000	全因死亡率	6.8±3.0
Detrano	2008	前瞻性研究	美国	6722	62.2±10.2	无症状人群,1~100,101~300,>300	冠状动脉事件	3.8
Nakanishi	2015	回顾性研究	美国	5584	56.6±11.6	无症状人群,1~99,100~399, ≥400	全因死亡率	10.4±3.1
Budoff	2017	前瞻性研究	美国	4209	60.6±8.2	有胸痛症状人群,1~ 100, 101~400,和>400	心血管不良事件	2.2
Budoff	2019	前瞻性研究	美国	1205	42.8 ±6.8	无症状人群伴有1型糖尿病, 1~100,101~300,和>300	心血管不良事件	7~9